期刊文献+

可视化微孔板芯片检测结核分枝杆菌利福平及异烟肼耐药性研究 被引量:3

Research on the drug resistance to rifampicin and isoniazid in the detection of Mycobacterium tuberculosis by visible microplate chip
下载PDF
导出
摘要 目的构建基于可视化微孔板芯片技术的结核分枝杆菌利福平和异烟肼耐药性检测方法。方法将针对结核分枝杆菌利福平和异烟肼耐药性相关基因设计的探针按预设模式固定于芯片表面构建基因芯片,并用其检测结核分枝杆菌的基因突变以判断其耐药性,阳性结果在芯片表面形成裸眼可见的色点。结果可视化微孔板芯片展示了稳定的试验结果,在50株异烟肼耐药株中检出40株(80%),主要为katG基因315位突变;在20株利福平耐药株中检出15株(75%),主要为rpoB基因531及526位突变。芯片鉴定阳性样本经聚合酶链反应(PCR)测序比对,其结果与芯片结果完全相符。结论可视化微孔板芯片用于检测结核分枝杆菌利福平和异烟肼耐药性具有较高的特异性和敏感性,该方法可以快速、准确、方便地应用于结核分枝杆菌耐药性的检测。 Objective To establish a method based on visible microplate chip for the detection of rifampicin and isoniazid resistance to Mycobacterium tuberculosis. Methods Gene chip was constructed by immobilizing default mode probes against genes associated with rifampicin and isoniazid resistance to Mycobacterium tuberculosis on the surface of gene chip. Drug resistance was identified by the prepared gene chip to detect the relative gene mutation, and the positive results, a color dot on the surface of gene chip, can be observed by naked eye. Results The prepared visible microplate chip showed stable detection results. The 40 of 50 ( 80% ) strains were resistant to isoniazid with a high mutation site of 315 codon within katG gene, and 15 of 20 (75%) strains were resistant to rifampicin with a high mutation site of 531 and 526 codons within rpoB gene. The results from the gene chip detection were consistent with the polymerase chain reaction(PCR) sequencing analysis. Conclusions The prepared visible microplate chip with good specificity and sensitivity is a fast, accurate and convenient mothod, and is promising for the detection of rifampicin and isoniazid resistance to Mycobacterium tuberculosis.
出处 《检验医学》 CAS 2013年第8期693-697,共5页 Laboratory Medicine
基金 深圳出入境检验检疫局科技计划项目(SZ20090021)
关键词 微孔板芯片 结核分枝杆菌 耐药性 利福平 异烟肼 Microplate chip Mycobacterium tuberculosis Drug resistance Rifampicin Isoniazid
  • 相关文献

参考文献7

二级参考文献19

  • 1梁莉,乐军,李瑶,肖和平,王洪海.利用基因芯片技术检测结核分支杆菌耐利福平分离株rpoB基因突变的研究[J].中华医院感染学杂志,2005,15(8):841-844. 被引量:7
  • 2吴雪琼,张琼,张俊仙,梁建琴,鲁红丽,李洪敏,张洪恩,陆阳,荣利,吕翠环,张广宇,邢婉丽.应用基因芯片分析结核分枝杆菌常见耐药基因型的研究[J].中国防痨杂志,2006,28(1):4-10. 被引量:29
  • 3张俊仙,吴雪琼,邢婉丽,张琼,梁建琴,张洪恩,陆阳,张广宇,李洪敏,阳幼荣.应用基因芯片技术检测耐利福平结核分枝杆菌基因型[J].中国现代医学杂志,2007,17(13):1572-1577. 被引量:6
  • 4梁莉,张滢蓉,乐军,景玲杰,高荣梁,肖和平.上海市非结核分枝杆菌感染趋势及耐药分析[J].中华医院感染学杂志,2007,17(7):895-897. 被引量:40
  • 5Guo Y, Zhou Y, Wang C, et al. Rapid, accurate determina- tion of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system[J]. Int J Tuberc Lung Dis, 2009, 13(7) : 914-920.
  • 6Glassroth J. Pulmonary disease due to nontuberculous myco- bacteria[J]. Chest,2008,133(1) :243-251.
  • 7Broxmeyer L, Sosnowska D, Miltner E, etal. Killing of My- cobacterium avium and Mycobacterium tuberculosis by a my- cobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens[J]. J Infect Dis,2002,186(8) :1155-1160.
  • 8Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug resistant tuberculosis[J ]. Respir Med,2009,103(12) : 1777-1790.
  • 9Zhu L, Jiang G, Wang S, etal. Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum[J]. J Clin Microbiol, 2010,48 (10) : 3654-3660.
  • 10Kim BJ, Lee KH, Yun YJ, Park EM, Park YG, Bai GH, Cha CY, Kook YH. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuherculous mycohacteria by polymerase chain reaction-single strand conformation polymor- phism and sequence analysis of the RNA polymerase gene (rpoB) [J]. J Microbiol Methods, 2004, 58(1):111-118.

共引文献37

同被引文献71

  • 1J.A.Caminero,夏辉(译),刘宇红(校).耐多药结核病:流行病学,危险因素及病人发现[J].国际结核病与肺部疾病杂志,2010(4):382-390. 被引量:16
  • 2王洁,崔振玲,胡忠义,张滢蓉,乐军,张文宏,翁心华.噬菌体法同时检测四种一线抗结核药物耐药性[J].中华传染病杂志,2006,24(2):102-105. 被引量:31
  • 3Chia - Chuan Yu, Chih - Yen Chang, Chun - Eng Liu, Li - Fong Shih, et al. Drug Resistance Pattern of Mycobac- terium Tuberculosis Complex at a Medical Center in Cen- tral Taiwan,2003 - 2007 [ J ]. Microbiol Immunol Infect, 2010,43 (4) :285 - 290.
  • 4Naima Fasih, Yasraba Rafiq, etal. High Isoniazid Resist- ance Rates in Rifampicin Susceptible Mycobacterium tu- berculosis Pulmonary Isolates from PaKistan [ J ] . Department of Pathology and Microbiology, 2012, 7 (11):1 -4.
  • 5Van klingeren B, Dessens - kroon M, Van der laan T, etal. Drug susceptibility testing of Mycobacterium tuber- culosis complex by use a high - throughput, absolute concentration method[ J]. American Society for Microbi- ology. 2007,45 ( 8 ) :2662 - 2668.
  • 6KIM PS, MAKHENE M, SIZEMORE C, et al. Viewpoint: challenges and opportunities in tuberculosis research [J]. J Infect Dis, 2012, 205 ( Suppl 2 ) : $347-$352.
  • 7RAVIGLIONE M, MARAIS B, FLOYD K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments [J]. Lancet, 2012, 379 (9829) : 1902-1913.
  • 8World Health Organization. Global tuberculosis report 2014 [M]. Switzerland: World Health Organization, 2014: XI - XI.
  • 9CHIEN JY, LAI CC, SHENG WH, et al. Pulmonary infection and colonization with nontuberculous myeobacteria, Taiwan, 2000-2012 [J]. Emerg Infect Dis, 2014, 20 ( 8 ) : 1382-1385.
  • 10PREVOTS DR, MARRAS TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review [J]. Clin Chest Med, 2015, 36 ( 1 ) : 13-34.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部